These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 33956869)

  • 21. Radioligand Assay-Based Detection of Antibodies against SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan.
    Matsunaga H; Makino A; Kato Y; Murakami T; Yamaguchi Y; Kumanogoh A; Oba Y; Fujimi S; Honda T; Tomonaga K
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.
    Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ
    Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of SARS-CoV-2 East Java isolate, Indonesia.
    Rantam FA; Prakoeswa CRS; Tinduh D; Nugraha J; Susilowati H; Wijaya AY; Puspaningsih NNT; Puspitasari D; Husada D; Kurniati ND; Aryati A
    F1000Res; 2021; 10():480. PubMed ID: 34621509
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
    Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
    Front Immunol; 2020; 11():609242. PubMed ID: 33424863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study.
    Comar M; Benvenuto S; Lazzerini M; Fedele G; Barbi E; Amaddeo A; Risso FM; Strajn T; Di Rocco P; Stefanelli P; Rezza G
    Ital J Pediatr; 2021 Jun; 47(1):131. PubMed ID: 34090486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.
    Herzberg J; Vollmer T; Fischer B; Becher H; Becker AK; Sahly H; Honarpisheh H; Guraya SY; Strate T; Knabbe C
    Int J Infect Dis; 2021 Jan; 102():136-143. PubMed ID: 33075538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria.
    Olayanju O; Bamidele O; Edem F; Eseile B; Amoo A; Nwaokenye J; Udeh C; Oluwole G; Odok G; Awah N
    Am J Trop Med Hyg; 2021 Jan; 104(1):91-94. PubMed ID: 33185181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Coronavirus Antibody Among First Responders in Lubbock, Texas.
    Iwuji K; Islam E; Berdine G; Nugent K; Test V; Tijerina A
    J Prim Care Community Health; 2020; 11():2150132720971390. PubMed ID: 33161808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.
    Pastor-Barriuso R; Pérez-Gómez B; Hernán MA; Pérez-Olmeda M; Yotti R; Oteo-Iglesias J; Sanmartín JL; León-Gómez I; Fernández-García A; Fernández-Navarro P; Cruz I; Martín M; Delgado-Sanz C; Fernández de Larrea N; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Larrauri A; Pollán M;
    BMJ; 2020 Nov; 371():m4509. PubMed ID: 33246972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.
    Bird PW; Sandhu K; Fletcher O; Ames B; Toovey O; Tang JW
    J Med Virol; 2021 Oct; 93(10):6050-6053. PubMed ID: 34173993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing for COVID-19: a few points to remember.
    Krátká Z; Luxová Š; Malíčková K; Fürst T; Šimková H
    Cas Lek Cesk; 2020; 159(2):72-77. PubMed ID: 32434339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of Immunoglobulin M and G Antibodies against SARS-CoV-2 Virus: A Systematic Review and Meta-Analysis Study.
    Fathi M; Vakili K; Sayehmiri F; Mohamadkhani A; Ghanbari R; Hajiesmaeili M; Rezaei-Tavirani M
    Iran J Immunol; 2021 Mar; 18(1):34-46. PubMed ID: 33787512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
    Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X
    J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.